# PCORI CER 2026 - Application Checklist

**Deadline**: Cycle 2 LOI: April 28, 2026 | Full App: September 1, 2026
**Priority**: üî¥ HIGH PRIORITY (Research Track)
**Last Updated**: 2026-02-03
**Application Type**: Two-stage (LOI then Full Application)

---

## ‚ö†Ô∏è DEADLINE STATUS

| Cycle | LOI Deadline | Full Application | Status |
|-------|--------------|------------------|--------|
| Cycle 1 | Jan 6, 2026 | May 5, 2026 | ‚ùå **MISSED** |
| **Cycle 2** | **Apr 28, 2026** | **Sept 1, 2026** | üü¢ **TARGET** |

**Action Required**: Begin LOI development NOW for April 28, 2026 deadline.

---

## CRITICAL FIRST STEPS

> **PATIENT ENGAGEMENT REQUIRED**: PCORI mandates authentic patient/stakeholder engagement throughout the research process. This is not optional - applications without demonstrated patient partnership will not be funded.

**Required Actions**:
1. [ ] Establish Patient Advisory Board (PAB) before LOI submission
2. [ ] Engage PAB in research question development
3. [ ] Document engagement structure and compensation plan

**Application Portal**: PCORI Online - https://pcori.org/funding-opportunities

---

## CRITICAL PCORI REQUIREMENTS

### Six Foundational Expectations for Partnerships

All PCORI applications MUST demonstrate:

1. ‚òê **Authentic Partnership** - Patients/stakeholders as true partners
2. ‚òê **Meaningful Engagement** - Not token involvement
3. ‚òê **Co-Learning** - Bidirectional knowledge exchange
4. ‚òê **Sustainability** - Long-term relationship building
5. ‚òê **Transparent Processes** - Open communication
6. ‚òê **Equity and Power-Sharing** - Balanced decision-making

---

## Pre-Application Requirements

### PCORI Registration

- [ ] Create PCORI Online account
- [ ] Register organization in PCORI system
- [ ] Verify authorized organizational representative

### Research Team Assembly

- [ ] Identify research-track PI with PCORI/CER experience
- [ ] Assemble co-investigators (methods, clinical, community)
- [ ] Identify biostatistician for complex design
- [ ] Engage FIU IRB for preliminary consultation
- [ ] Coordinate with FIU Office of Research

---

## Patient Advisory Board Requirement

### Composition Needed
- [ ] 3-5 community members/patients from NHELP service area
- [ ] 1-2 CHW representatives
- [ ] 1-2 community organization partners
- [ ] Clinical stakeholder representation

### Engagement Documentation
- [ ] Advisory board roster with roles
- [ ] Meeting schedule and format
- [ ] Co-design activities documentation
- [ ] Letters of commitment from members
- [ ] Compensation plan for patient partners

### Engagement Structure
- [ ] Quarterly meetings minimum
- [ ] Co-design of research questions
- [ ] Review of study materials
- [ ] Input on dissemination strategy

---

## LOI Materials Needed

**LOI Deadline**: April 28, 2026

### Research Concept
- [ ] Clear research question (comparative effectiveness)
- [ ] Study design overview
- [ ] Intervention vs. control description
- [ ] Primary and secondary outcomes
- [ ] Patient-centered justification

### Patient/Stakeholder Engagement Plan
- [ ] Current engagement activities
- [ ] Planned engagement throughout project
- [ ] Patient Advisory Board description
- [ ] Compensation approach

### Team Information
- [ ] PI biosketches
- [ ] Patient/stakeholder partners identified
- [ ] Research team qualifications
- [ ] Institutional capacity

### Preliminary Budget
- [ ] Budget range estimate
- [ ] Key cost categories

---

## Full Application Materials (If Invited)

**Full Application Deadline**: September 1, 2026

### Research Plan
- [ ] Detailed research protocol
- [ ] Statistical analysis plan
- [ ] Sample size justification
- [ ] Data management plan
- [ ] Timeline with milestones

### Patient Engagement
- [ ] Detailed engagement plan throughout study
- [ ] Patient advisory board operations
- [ ] Co-design activities description
- [ ] Dissemination involvement plan
- [ ] Patient partner compensation budget

### Budget Documents
- [ ] Detailed line-item budget
- [ ] Budget justification
- [ ] Subcontract budgets (if applicable)
- [ ] Patient engagement costs itemized

### Supporting Documents
- [ ] IRB approval or exemption plan
- [ ] Data use agreements
- [ ] Letters of support from community partners
- [ ] Letters from Patient Advisory Board members
- [ ] Collaboration agreements

---

## Proposed Research Concept

### Title
"Comparative Effectiveness of AI-Enhanced SDOH Screening and Navigation vs. Standard Care in Underserved Communities"

### Research Question
Does FIU Thrive-enhanced SDOH screening and closed-loop referral improve patient-centered outcomes compared to standard community health center care?

### Study Arms
1. **Intervention:** FIU Thrive + CHW navigation + closed-loop referrals
2. **Control:** Standard SDOH screening and referral processes

### Outcomes
- **Primary:** SDOH needs addressed at 6 months
- **Secondary:** Health service utilization, patient satisfaction, health status

---

## Key Messaging Points

- **Patient-Centered**: Research question must matter to patients, not just clinicians
- **Comparative Effectiveness**: Must compare two or more approaches
- **Health Equity**: PCORI prioritizes research addressing disparities
- **Real-World Implementation**: Pragmatic design in actual practice settings
- **Meaningful Engagement**: Patient partners are co-investigators, not just subjects
- **Actionable Results**: Research must lead to practice change decisions

---

## Timeline (Updated for Cycle 2)

| Date | Action | Status |
|------|--------|--------|
| Feb 2026 | Identify PI and research team | üü¢ CURRENT |
| Feb-Mar 2026 | Establish Patient Advisory Board | üîµ PENDING |
| Mar 2026 | Develop research concept with PAB input | üîµ PENDING |
| Apr 1-15, 2026 | Finalize LOI materials | üîµ PENDING |
| Apr 20, 2026 | PAB review of LOI | üîµ PENDING |
| **Apr 28, 2026** | **LOI DEADLINE** | üéØ TARGET |
| May-Jun 2026 | Await LOI decision | ‚è≥ |
| Jun-Jul 2026 | Draft full application (if invited) | üîµ PENDING |
| Aug 2026 | PAB review, internal review | üîµ PENDING |
| **Sept 1, 2026** | **FULL APPLICATION** | üéØ TARGET |

---

## Contacts

- **PCORI Website:** [pcori.org/funding-opportunities](https://www.pcori.org/funding-opportunities)
- **Application Portal:** PCORI Online
- **Technical Assistance:** Contact PCORI program staff before LOI

---

## Common Pitfalls to Avoid

1. **Weak Patient Engagement** - Token involvement is not acceptable
2. **Not Comparative** - PCORI requires comparing interventions
3. **Clinical Focus Only** - Patient-centered outcomes required
4. **Late PAB Formation** - Should exist before LOI submission
5. **No Compensation Plan** - Patient partners must be compensated
6. **Missing Health Equity** - Must address equity advancement
7. **Last-Minute Submission** - Submit early for system issues

---

## Post-Submission Actions

### After LOI
- [ ] Save submission confirmation
- [ ] Note expected decision timeline
- [ ] Continue PAB engagement activities
- [ ] Begin drafting full application sections

### After Full Application
- [ ] Save submission confirmation
- [ ] Prepare for Just-in-Time requests
- [ ] Continue community engagement
- [ ] Document lessons learned

---

## Resources

- **PCORI Funding**: https://pcori.org/funding-opportunities
- **Methodology Standards**: https://pcori.org/research/methodology
- **Patient Engagement**: https://pcori.org/engagement
- **Consider**: Engagement Awards ($100K-$500K) as relationship-builder

---

## Notes

- Patient engagement is CRITICAL - not optional
- Review recently funded CER projects for guidance
- Connect with PCORI program officers before LOI
- ClinicalTrials.gov registration required if applicable

---

*Checklist updated: 2026-02-03*
*Cycle 2 deadlines: LOI Apr 28, 2026 | Full Sept 1, 2026*
